ARCHIVES

NCI Considering Adoption Of NIGMS Guidelines To Limit Growth Of Renewals, Ensure New Grants

This article is from The Cancer Letter archive.

Vol. 16 No. 46 | November 30, 1990

Download PDF Visit The Full Archive

Related Articles

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

In Brief: Healy to Name Jay Moskowitz Deputy Direct, Promote Mahoney To Deputy Budge Director

March 6, 1992

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

FDA says green tea unlikely to prevent cancer.

July 8, 2005

Dingell: “Unable To Vouch” For Staff Report On NCI’s Gallo

February 10, 1995

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

May 27, 2005